Physician profile
Fernando Quirindongo Solano
NPI 1134235088
$2,915.19
in general payments reported to CMS, 2019-2025
24 companies · $2,137 in 2025
The $2,137 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $82.92 · 2021: $75.42 · 2022: $398 · 2024: $112 · 2025: $2,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,543 · Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,542.73 |
| Food and Beverage | $706.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,591.46 | 2025 | |
| Stryker Corporation | $287.75 | 2024-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Viaflow |
| Organogenesis INC. | $198.61 | 2022-2025 | Simplimax |
| Aroa Biosurgery Incorporated | $144.68 | 2022 | |
| Amgen INC. | $142.72 | 2025 | Krystexxa |
| Bioventus LLC | $90.50 | 2019-2022 | |
| Pfizer INC. | $64.04 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $52.41 | 2025 | |
| Nevro Corp. | $51.43 | 2022 | |
| Horizon Therapeutics Plc | $35.16 | 2022 | |
| Convatec INC. | $29.98 | 2022 | |
| Wright Medical Technology, INC. | $25.42 | 2020 | |
| Acera Surgical, INC. | $22.39 | 2025 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $21.73 | 2022 | |
| Medtronic, INC. | $18.72 | 2025 | Intellis Adaptivestim |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $18.55 | 2022 | |
| Grt US Holding, INC. | $17.96 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.60 | 2021 | |
| Linvatec Corporation | $16.21 | 2021 | |
| Alfasigma USA, INC. | $15.33 | 2020 | |
| Acell, INC. | $15.10 | 2019 | |
| Innovation Technologies INC | $14.76 | 2025 | Irrisept |
| Paratek Pharmaceuticals, INC. | $12.12 | 2021 | |
| Zyla Life Sciences, INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Quirindongo Solano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.